What is the appropriate vitamin A dosage for a 1‑year‑old child with measles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vitamin A Dosage for 1-Year-Old with Measles

A 1-year-old child with measles should receive 100,000 IU of vitamin A orally on day 1, with a second dose of 100,000 IU on day 2 if the child has complicated measles (pneumonia, otitis, croup, diarrhea with moderate/severe dehydration, or neurological problems). 1

Dosing Algorithm

Uncomplicated Measles

  • Day 1: 100,000 IU oral vitamin A 1
  • Day 2: No additional dose needed unless complications develop 1
  • Repeat: Every 3 months as part of routine vitamin A supplementation schedule 1

Complicated Measles

Children with any of the following complications require a second dose:

  • Pneumonia
  • Otitis media
  • Croup
  • Diarrhea with moderate or severe dehydration
  • Neurological problems 1

Dosing for complicated cases:

  • Day 1: 100,000 IU oral vitamin A
  • Day 2: 100,000 IU oral vitamin A (second dose) 1

Eye Signs of Vitamin A Deficiency

If any eye symptoms are present (xerosis, Bitot's spots, keratomalacia, or corneal ulceration):

  • Day 1: 100,000 IU oral vitamin A
  • Day 2: 100,000 IU oral vitamin A
  • 1-4 weeks later: 100,000 IU oral vitamin A 1

Key Clinical Points

Age-based dosing is critical: Children less than 12 months of age receive half the standard dose (100,000 IU instead of 200,000 IU). 1 Since the patient is exactly 1 year old, they fall into the under-12-months category and should receive 100,000 IU doses.

Evidence for mortality reduction: Two doses of vitamin A (given on consecutive days) reduce all-cause mortality by 64% (RR 0.36,95% CI 0.14-0.82) and pneumonia-specific mortality by 67% (RR 0.33,95% CI 0.08-0.92) in children with measles. 2, 3 The effect is most pronounced in children under 2 years of age, with an 82% reduction in mortality risk (RR 0.18,95% CI 0.03-0.61). 2

Single dose limitations: A single dose of 200,000 IU (or 100,000 IU for infants) was not associated with reduced mortality (RR 0.77,95% CI 0.34-1.78), which is why the two-dose regimen is recommended for complicated cases. 2, 3

Common Pitfalls

Do not withhold if vitamin A was given in the previous month: The guideline specifically states to give vitamin A if the child has NOT received it during the previous month, but this is a recommendation to avoid unnecessary dosing in routine supplementation—not a contraindication during acute measles. 1 For children with complicated measles or eye signs, vitamin A should be given regardless.

Formulation matters: Water-based vitamin A preparations showed greater mortality reduction (81%, RR 0.19) compared to oil-based preparations (48%, RR 0.52), though both are effective. 2 Use whatever formulation is available, but water-based is preferable if accessible.

Assess for complications daily: The decision to give a second dose depends on identifying complications, which may not be apparent on day 1. Monitor for development of pneumonia, croup, severe diarrhea, or other complications through day 2. 1

Vomiting is common: Vitamin A supplementation increases the risk of vomiting within 48 hours (RR 1.97,95% CI 1.44-2.69), but this is transient and does not outweigh the mortality benefit. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.